The impact of the HIV reverse transcriptase M184V mutation in combination with single thymidine analogue mutations on nucleoside reverse transcriptase inhibitor resistance in clinical samples from a large patient database

被引：0
|
作者：
Ross, L
Parkin, N
Bates, M
Fisher, R
St Clair, M
Tisdale, M
Lanier, R
机构：
[1] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[2] GlaxoSmithKline Inc, Stevenage, Herts, England
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
141
引用
收藏
页码：U134 / U135
页数：2
相关论文
共 50 条
  • [21] Endogenous reverse transcriptase assays reveal synergy between combinations of the M184V and other drug resistance-conferring mutations in interactions with nucleoside analog triphosphates
    Quan, YD
    Gu, ZX
    Li, XG
    Liang, C
    Parniak, MA
    Wainberg, MA
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 277 (02) : 237 - 247
  • [22] Elucidating the molecular interactions of the <it>L</it>-nucleotide analogs with the Complex of HIV-1 Reverse Transcriptase and DNA and the mechanism of drug resistance conferred by the M184V mutation
    Suo, Zucai
    FASEB JOURNAL, 2020, 34
  • [23] The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine
    Sprout, M
    Pozniak, AL
    Peeters, M
    Winters, B
    Hoetelmons, R
    Graham, NM
    Gazzard, BG
    ANTIVIRAL THERAPY, 2005, 10 (02) : 357 - 361
  • [24] Pressure of zidovudine accelerates the reversion of lamivudine resistance-conferring M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1
    Diallo, K
    Oliveira, M
    Moisi, D
    Brenner, B
    Wainberg, MA
    Götte, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) : 2254 - 2256
  • [25] Diminished representation of HIV-1 variants containing protease associated mutations and M184V in reverse transcriptase (RT) in primary HIV-1 infection
    Wainberg, MA
    Brenner, B
    Routy, JP
    Moisi, D
    Roger, M
    Turner, D
    MICROBIOLOGICA, 2004, 27 (02): : 145 - 145
  • [26] The H208Y mutations in reverse transcriptase is significantly associated with NRTI-exposure, M184V and TAM1 mutation pathways
    Geretti, A. M.
    Sabin, C.
    Dunn, D.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S158 - S158
  • [27] Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
    Xu, Hong-Tao
    Martinez-Cajas, Jorge L.
    Ntemgwa, Michel L.
    Coutsinos, Dimitrios
    Frankel, Fernando A.
    Brenner, Bluma G.
    Wainberg, Mark A.
    RETROVIROLOGY, 2009, 6
  • [28] Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
    Hong-Tao Xu
    Jorge L Martinez-Cajas
    Michel L Ntemgwa
    Dimitrios Coutsinos
    Fernando A Frankel
    Bluma G Brenner
    Mark A Wainberg
    Retrovirology, 6
  • [29] Prevalence and quantitative phenotypic resistance patterns of specific nucleoside analogue mutation combinations and of mutations 44 and 118 in reverse transcriptase in a large dataset of recent HIV-1 clinical isolates
    Van Houtte, M
    Lecocq, P
    Bacheler, L
    ANTIVIRAL THERAPY, 2003, 8 (03) : U47 - U47
  • [30] Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine
    Xu, Hong-Tao
    Colby-Germinario, Susan P.
    Asahchop, Eugene L.
    Oliveira, Maureen
    McCallum, Matthew
    Schader, Susan M.
    Han, Yingshan
    Quan, Yudong
    Sarafianos, Stefan G.
    Wainberg, Mark A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) : 3100 - 3109
12345